BENJAMIN CARSON SR - 07 Dec 2023 Form 3 Insider Report for GALECTIN THERAPEUTICS INC (GALT)

Role
Director
Signature
Jack W. Callicutt, by power of attorney
Issuer symbol
GALT
Transactions as of
07 Dec 2023
Net transactions value
$0
Form type
3
Filing time
16 Feb 2024, 08:50:09 UTC
Previous filing
23 May 2023
Next filing
07 Feb 2024
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding GALT Common Stock Options 07 Dec 2023 Common Stock 100,000 $2.23 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The Common Stock Options were granted to the Reporting Person by the Issuer in connection with services to be provided by the Reporting Person as a consultant prior to the Reporting Person's election to the Board of Directors. The options vested and became exercisable upon several vesting dates beginning on July 16, 2021 and ending April 16, 2023.